SHARL AZAR: Open Payments
NPI 1114244134 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,819 in 6 payments from 3 companies in 2025. Trend: 2023 $1,485 · 2024 $0 · 2025 $7,819
Consulting: $7,694Food & beverage: $125
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 3 | $5,658 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $2,036 |
| Novo Nordisk Inc | 1 | $125 |
Products named: PYRUKYND.
Industry payments across MA — which companies pay providers there.
